People with Medicare Will Face Higher Costs for Some Orphan Drugs Due to Changes in the New Tax and Budget Law
This brief analyzes changes in the new tax and budget reconciliation law that modify which…
People with Medicare Will Face Higher Costs for Some Orphan Drugs Due to Changes in the New Tax and Budget Law
This brief analyzes changes in the new tax and budget reconciliation law that modify which drugs will be selected for Medicare drug price negotiation, which will lead to higher Medicare spending and higher costs for beneficiaries who take these medications.
UniQure Gene Therapy’s Clinical Trial Results Keep It on Path to Become First Huntington’s Treatment
UniQure plans a first quarter 2026 FDA submission for AMT-130 as a treatment for Huntington’s disease. This gene therapy delivers microRNA designed to silence the mutated gene that produces a protein driving this disorder, which so far has no FDA-approved therapies. The post UniQure Gene Therapy’s Clinical Trial Results Keep It on Path to Become…
Tracking State Actions on Vaccine Policy and Access
With recent federal actions to curtail vaccine access, many states have announced actions intended to maintain broader access. This issue brief provides a snapshot of this rapidly changing landscape, tracking which states have instituted changes in response to or in anticipation of administration policy changes.
Healthcare’s Security Awakening Testing Patience of Medical Device Buyers
Customers are no longer willing to accept vague assurances about security. Instead, they expect evidence of secure design, documented vulnerability management processes, and transparency about software components. The post Healthcare’s Security Awakening Testing Patience of Medical Device Buyers appeared first on MedCity News.
How Much and Why Premiums are Going up for Small Businesses in 2026
This analysis of preliminary rate filings from 318 insurers across all 50 states and DC finds that small businesses with Affordable Care Act (ACA)-compliant plans could face a median premium increase of 11% for 2026.
Rush To Regulation: What New NHS Compliance Requirements For Ambient Voice Technology Mean For US Providers
The proliferation and rapid adoption of AVT in clinical settings has not gone unnoticed, and NHS England has made it clear that the use of these tools must now meet stringent compliance standards. The post Rush To Regulation: What New NHS Compliance Requirements For Ambient Voice Technology Mean For US Providers appeared first on MedCity…
The Role of SHIPs in Helping People with Medicare Navigate Their Coverage
The State Health Insurance Assistance Program (SHIP) offers free counseling to help millions of Medicare beneficiaries make decisions about coverage. However, federal funding has been modest over the last decade, and federal administration of the program appears to be in transition.
She Had a Broken Arm, No Insurance — And a $97,000 Bill
As soon as she fell, Deborah Buttgereit knew she couldn’t avoid going to the hospital. “I could hear the bones moving around in my elbow,” said Buttgereit, who was 60 when she slipped on a patch of ice in December outside her apartment in Bozeman, Montana. Emergency room scans showed she had fractured her left…
Trump Claims ‘No Downside’ to Avoiding Tylenol During Pregnancy. He’s Wrong.
“There’s no downside” to avoiding Tylenol or acetaminophen use while pregnant. President Donald Trump on Sept. 22, 2025, in a press conference Obstetricians have long advised their pregnant patients that Tylenol is the safest option to reduce fever or pain. President Donald Trump stood before a national audience on Sept. 22 and contradicted that. “Don’t…
Amid Confusion Over US Vaccine Recommendations, States Try To ‘Restore Trust’
When the CDC’s Advisory Committee on Immunization Practices met last week, confusion filled the room. Members admitted they didn’t know what they were voting on, first rejecting a combined measles-mumps-rubella-chickenpox vaccine for young toddlers, then voting to keep it funded minutes later. The next day, they reversed themselves on the funding. Now Jim O’Neill, the…
